1. Rotondi M, Magri F, Chivato L. Thyroid and obesity: not a one way interaction. Clin Endocrinol(Oxf). 2011; 96(2): 344-346.
2. Balagopal P, George D, Sweeten S, Mann KJ, Yarandi H, Mauras N, et al. Response of fractional synthesisrate (FSR) of fibrinogen, concentration of D dimer and fibrinolytic balance to physical activity based interventionin obese children. Journal of Thrombosis and Haemostasis. 2008; 6(8):1296-303.
3. Yang R.Z, Lee M.J, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology - Endocrinology and Metabolism. 2006; 290(6): 1253–1261.
4. Kazama K, Usui T, Okada M, Hara Y, Yamawaki H. Omentin plays an anti-inflammatory role through inhibition of TNF-a –induced superoxide production in vascular smooth muscle cells. European Journal of Pharmacology. 2012; 686(1-3): 116–123.
5. Xie H, Xie PL, Wu XP, Chen SM, Zhou HD, Yuan LQ, et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovascular Research. 2011; 92(2): 296–306.
6. De Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007; 56(6): 1655 – 1661.
7. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normalsubjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Research and Clinical Practice. 2010; 88(1): 29 –33.
8. Ji L, Radak Z, Goto S. Hormesis and exercise: how the cell copes with oxidative stress. American Journal of Pharmacology and Toxicology. 2008; 3(1): 41-55.
9. Pitsavos C, Panagiotakos DB, Tambalis KD, Chrysohoou C, Sidossis LS, Skoumas J, et al. Resistance exercise plus to aerobic activities is associated with better lipids’ profile among healthy individuals: the ATTICA study. The Quarterly journal of medicine. 2009; 102(9): 609–616.
10. Marques E, Carvalho J, Soares JMC, Marques F, Mota J. Effects of resistance and multicomponent exercise on lipid profiles of older women. Maturitas. 2009; 63(1): 84-88.
11. 11. Saremi A. Asghari M. Ghorbani A. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. Journal of Sports Sciences. 2010; 28(9): 993-8.
12. فتحی رزیتا، محمدی صفرعلی، طالبی گرکانی الهه، رودباری فاطمه، علی‌نژاد محمد. پاسخ حاد و تأخیری فعالیت هوازی بر سطوح پلاسمایی امنتین-1 موش‌های صحرایی نر دیابتی. ورزش و علوم زیست حرکتی. 1390؛ 5 (1): 55-48.
13. صفرزاده علی‌رضا، حاجی زاده رستمی ملیحه، طالبی گرکانی الهه، فتحی رزیتا. تأثیر تمرین مقاومتی فزاینده بر غلظت سرمی امنتین-1 و نیمرخ لیپیدی موش های صحرایی نر. نشریه علوم زیستی حرکتی. 1393؛ 6 (3): 300-287.
14. Brzycki M. A practical approach to strength training. 1st ed. Mc Graw-Hill.Womens sports fitness. 1993; 268(8): 5457-63.
15. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Medicine & Science in Sports & Exercise. 1980; 12(3): 175-181.
16. Cai, RC,;Wei, L,; DI, JZ.; Yu, H.Y.; Bao, Y.Q.; Jia, W.P. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2009; 89(6):381-384.
17. Antuna-Puente B, Feve B, Fellahi S, and Bastard JP. Adipokines: The missing link between insulin resistance and obesity. Diabetes and Metabolism. 2008; 34(1): 2-11.
18. Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, and Fernández-Real JM. Circulating omentin concentration increases after weight loss. Nutrition and Metabolism. 2010; (9)7: 27.
19. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, and Randeva HS. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes. 2008; 57(4): 801-8.
20. Shaker M, Mashhadani ZI, and Mehdi AA. Effect of Treatment with Metformin on Omentin-1, Ghrelin and other Biochemical, Clinical Features in PCOS Patients. Oman Medical Journal. 2010; 25(4): 289-93.
21. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier JF. Absence of exercise- induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. European Journal of Endocrinology. 2003; 149(5): 421-424.
22. Abdel-lateif, D. M., & El-Shaer, S. S. Association between changes in serum vaspin concentrations and changes of anthropometric and metabolic variables in obese subjects after weight reduction. Journal of American Science. 2012; 8(4): 606-611.
23. یاوری عباس، نجفی‌پور فرزاد، علی عسگرزاده اکبر، نیافر میترا، مبصری مجید، نیکو‌خصلت سعید. تأثیر تمرینات هوازی، مقاومتی و ترکیبی بر کنترل قندخون و ریسک فاکتور‌های قلبی- عروقی در بیماران دیابتی نوع 2. مجله پزشکی دانشگاه علوم پزشکی و خدمات بهداشتی- درمانی تبریز. 1390؛ 33(4): 91-82.
24. Fatouros, I. G., Chatzinikolaou, A., Tournis, S., Nikolaidis, M. G., Jamurtas, A. Z., Douroudos, I. I., et al. Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals. Diabetes care. 2009; 32(12): 2161-7.